Cargando…
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients
Immunomodulatory drugs (IMiDs) are effective in the treatment of multiple myeloma (MM), myelodysplastic syndrome with deletion of chromosome 5q and other haematological malignancies. Recent studies showed that IMiDs bind to cereblon (CRBN), a substrate receptor of the CRL4–CRBN complex, to induce th...
Autores principales: | Barankiewicz, Joanna, Szumera-Ciećkiewicz, Anna, Salomon-Perzyński, Aleksander, Wieszczy, Paulina, Malenda, Agata, Garbicz, Filip, Prochorec-Sobieszek, Monika, Misiewicz-Krzemińska, Irena, Juszczyński, Przemysław, Lech-Marańda, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235391/ https://www.ncbi.nlm.nih.gov/pubmed/34207079 http://dx.doi.org/10.3390/jcm10122683 |
Ejemplares similares
-
CRL4(CRBN) E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma
por: Barankiewicz, Joanna, et al.
Publicado: (2022) -
CUL4-DDB1-CRBN E3 Ubiquitin Ligase Regulates Proteostasis of ClC-2 Chloride Channels: Implication for Aldosteronism and Leukodystrophy
por: Fu, Ssu-Ju, et al.
Publicado: (2020) -
P044: PIM kinases support protumoral and immunosuppressive phenotype and functions of macrophages in classical Hodgkin Lymphoma
por: Szydłowski, Maciej, et al.
Publicado: (2022) -
Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019) -
Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide
por: Fischer, Eric S., et al.
Publicado: (2014)